As per MRFR analysis, the Hepatitis E Diagnostic Test Market Size was estimated at 1.69 (USD Billion) in 2022. The Hepatitis E Diagnostic Test Market Industry is expected to grow from 1.81 (USD Billion) in 2023 to 3.2 (USD Billion) by 2032. The Hepatitis E Diagnostic Test Market CAGR (growth rate) is expected to be around 6.57% during the forecast period (2024 - 2032).
Key Hepatitis E Diagnostic Test Market Trends Highlighted
The global Hepatitis E diagnostic test market exhibits a growing demand due to the increasing prevalence of hepatitis E virus (HEV) infections worldwide.
Technological advancements in diagnostic techniques, such as the development of highly sensitive and specific molecular assays, have significantly contributed to the market growth.
Additionally, rising awareness about hepatitis E and the importance of early diagnosis drive the market expansion.
Key market drivers include the surge in hepatitis E outbreaks, particularly in developing countries with poor sanitation and hygiene practices. Opportunities for market expansion lie in the development of rapid and point-of-care diagnostic tests that can facilitate early detection and timely intervention in remote or resource-limited settings.
Recent trends in the market include the integration of artificial intelligence (AI) and machine learning (ML) algorithms into diagnostic platforms to enhance accuracy and efficiency. The market is also witnessing a shift toward non-invasive testing methods, such as saliva-based assays, for improved patient convenience and reduced discomfort.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Hepatitis E Diagnostic Test Market Drivers
Rising Prevalence of Hepatitis E Virus Infections
Hepatitis E is a viral infection that can cause inflammation of the liver. It is spread through contact with contaminated food or water, and it is a major public health concern in many developing countries. The World Health Organization (WHO) estimates that 20 million people are infected with hepatitis E each year, and that 3.4 million of these infections result in hospitalization.
The rising prevalence of hepatitis E virus infections is a major driver of the growth of the global Hepatitis E Diagnostic Test Market Industry.
As the number of people infected with hepatitis E increases, the demand for diagnostic tests to identify and treat the infection will also increase.
Increasing Awareness of Hepatitis E
The increasing awareness of hepatitis E is another major driver of the growth of the global Hepatitis E Diagnostic Test Market Industry. In the past, hepatitis E was often misdiagnosed as other liver diseases, such as hepatitis A or B.
However, as awareness of hepatitis E has increased, so has the demand for diagnostic tests to identify the infection. This increased awareness is due in part to the efforts of public health organizations and advocacy groups, which have worked to raise awareness of the disease and its symptoms.
As a result of these efforts, more people are aware of hepatitis E and are seeking testing for the infection.
Technological Advancements in Hepatitis E Diagnostics
The technological advancements in hepatitis E diagnostics are also driving the growth of the global Hepatitis E Diagnostic Test Market Industry. In the past, hepatitis E was diagnosed using serological tests, which detected antibodies to the virus.
However, these tests were not always accurate, and they could not be used to diagnose early-stage infections. In recent years, new diagnostic tests have been developed that are more accurate and sensitive than serological tests.
These new tests can be used to diagnose early-stage infections, and they can also be used to differentiate between hepatitis E and other liver diseases.
Hepatitis E Diagnostic Test Market Segment Insights
Hepatitis E Diagnostic Test Market Test Type Insights
The Global Hepatitis E Diagnostic Test Market is segmented by Test Type into Immunoassay-Based Tests, Molecular Diagnostics Tests, and Serological Tests. Among these segments, Immunoassay-Based Tests accounted for the largest market share in 2023, and is projected to continue its dominance throughout the forecast period.
The growth of this segment can be attributed to the increasing adoption of rapid diagnostic tests (RDTs), which are simple to use, provide quick results, and are cost-effective. The Molecular Diagnostics Tests segment is anticipated to be the fastest-growing segment in the Global Hepatitis E Diagnostic Test Market during the forecast period.
The growth of this segment can be attributed to the increasing demand for accurate and sensitive diagnostic tests for Hepatitis E virus (HEV). The Serological Tests segment is expected to witness steady growth over the forecast period, due to the continued use of traditional serological tests for the diagnosis of Hepatitis E.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Hepatitis E Diagnostic Test Market Sample Type Insights
The Global Hepatitis E Diagnostic Test Market is segmented by Sample Type into Serum, Plasma, and Fecal. Among these, the Serum segment held the largest market share in 2023, accounting for over 45% of the global market revenue. This dominance is attributed to the widespread availability of serum samples and the ease of collection compared to other sample types.
The Plasma segment is expected to witness significant growth over the forecast period, owing to the increasing adoption of plasma-based diagnostic tests for Hepatitis E virus (HEV) detection.
The Fecal segment is projected to grow at a steady pace due to the growing awareness of fecal-oral transmission of HEV.
Hepatitis E Diagnostic Test Market End User Insights
The end user segment of the Global Hepatitis E Diagnostic Test Market plays a crucial role in driving market growth. Hospitals account for a significant share of the market, owing to the increasing number of hepatitis E cases and the need for accurate and timely diagnosis.
Diagnostic laboratories are also major end users, as they provide specialized testing services for hepatitis E. Research institutes contribute to market growth by conducting research on new diagnostic methods and technologies. The growing focus on early detection and diagnosis of hepatitis E is expected to boost the demand for diagnostic tests, particularly in regions with high disease prevalence.
Hepatitis E Diagnostic Test Market Regional Insights
The regional market for Hepatitis E Diagnostic Tests is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East Africa. In 2023, the North American market held the largest market share, followed by Europe and Asia-Pacific.
The growth in the North American market is primarily attributed to the increasing prevalence of hepatitis E, the growing adoption of advanced diagnostic technologies, and the presence of well-established healthcare infrastructure. The European market is expected to witness steady growth due to the rising awareness about hepatitis E and the availability of advanced healthcare facilities.
The Asia-Pacific market is anticipated to grow at a significant rate, owing to the increasing healthcare expenditure and the growing awareness about hepatitis E in the region. The South American and Middle East Africa markets are expected to grow at a slower pace due to the limited healthcare infrastructure and the lower prevalence of hepatitis E in these regions.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Hepatitis E Diagnostic Test Market Key Players and Competitive Insights:
Major players in the Hepatitis E Diagnostic Test Market are focusing on developing innovative diagnostic tests to improve the accuracy and efficiency of hepatitis E diagnosis. The industry is characterized by the presence of leading players such as Abbott Laboratories, Beckman Coulter, bioMérieux, Chembio Diagnostics, and F. Hoffmann-La Roche.
These companies are investing heavily in research and development to gain a competitive edge and meet the growing demand for accurate and reliable diagnostic tests.
The Hepatitis E Diagnostic Test Market is expected to witness significant development in the coming years, driven by factors such as the rising prevalence of hepatitis E infections, increasing awareness about the disease, and government initiatives to control the spread of the virus.
The competitive landscape is expected to remain dynamic, with new entrants and existing players vying for market share.
Among the leading Hepatitis E Diagnostic Test Market players, Abbott Laboratories is a global leader in the development and manufacturing of diagnostic tests and systems. The company offers a range of diagnostic tests for hepatitis E, including the ARCHITECT i2000SR and ARCHITECT i4000SR systems.
These systems provide automated and rapid testing, enabling healthcare professionals to diagnose hepatitis E infections quickly and accurately. Abbott Laboratories has a strong distribution network and a wide customer base, which contributes to its leading position in the market.
A notable competitor in the Hepatitis E Diagnostic Test Market is bioMérieux, a French multinational corporation specializing in in vitro diagnostics. The company offers a range of diagnostic tests for hepatitis E, including the VIDAS HEV IgM and VIDAS HEV IgG tests.
These tests are designed to detect antibodies against the hepatitis E virus, enabling healthcare professionals to diagnose acute and chronic hepatitis E infections. bioMérieux has a strong presence in Europe and Asia-Pacific and is expanding its operations in emerging markets, which is expected to drive its growth in the Hepatitis E Diagnostic Test Market.
Key Companies in the Hepatitis E Diagnostic Test Market Include
Hepatitis E Diagnostic Test Market Industry Developments
The increasing prevalence of hepatitis E infection, technological advancements in diagnostic methods, and rising awareness about the disease are driving the market growth.
Recent developments include the launch of new diagnostic tests with improved sensitivity and specificity, such as the Wantai HAV/HEV IgM/IgG Rapid Test Cassette and the Biosynex HEV IgM/IgG Rapid Test.
Additionally, collaborations between diagnostic companies and research institutions are accelerating the development of novel tests with higher accuracy and faster turnaround times.
Hepatitis E Diagnostic Test Market Segmentation Insights
Hepatitis E Diagnostic Test Market Test Type Outlook
Hepatitis E Diagnostic Test Market Sample Type Outlook
Hepatitis E Diagnostic Test Market End User Outlook
Hepatitis E Diagnostic Test Market Regional Outlook
| Report Attribute/Metric | Details |
| Market Size 2022 | 1.69 (USD Billion) |
| Market Size 2023 | 1.81 (USD Billion) |
| Market Size 2032 | 3.2 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 6.57% (2024 - 2032) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2023 |
| Market Forecast Period | 2024 - 2032 |
| Historical Data | 2019 - 2023 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Danaher, Fujirebio, DiaSorin, Siemens Healthineers, Thermo Fisher Scientific, BioRad Laboratories, Tulip Diagnostics Pvt. Ltd., Sysmex Corporation, F. HoffmannLa Roche AG, Qiagen, Ortho Clinical Diagnostics, Trinity Biotech, Abbott Laboratories |
| Segments Covered | Test Type, Sample Type, End User, Regional |
| Key Market Opportunities | 1 Growing prevalence of hepatitis E globally 2 Improved healthcare infrastructure in developing countries 3 Technological advancements leading to more sensitive tests 4 Increasing awareness about the disease and its diagnosis 5 Government initiatives to support early detection |
| Key Market Dynamics | Technological advancements, increasing prevalence, government initiatives, rising awareness, and expanding healthcare infrastructure |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Hepatitis E Diagnostic Test Market reached USD 1.81 billion in 2023.
The market is expected to reach USD 3.2 billion by 2032.
The market is expected to expand at a CAGR of 6.57% from 2024 to 2032.
Asia-Pacific is expected to hold the largest market share due to the high prevalence of hepatitis E in the region.
Hepatitis E diagnostic tests are used to detect and diagnose Hepatitis E virus infections.
Major players include Abbott Laboratories, Bio-Rad Laboratories, and Siemens Healthineers.
Rising awareness of hepatitis E, increasing demand for early diagnosis, and technological advancements are driving market growth.
Limited access to testing facilities in developing regions and the emergence of new strains of the virus pose challenges.
The market is expected to witness increased competition with the entry of new players and strategic partnerships.
Expanding healthcare infrastructure in developing regions and the development of rapid and cost-effective diagnostic tests present growth opportunities.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
